Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. Rossello X, Riquelme JA, Davidson SM, Yellon DM. J Cell Mol Med. 2017 Nov 20. doi: 10.1111/jcmm.13394
Exosomes and cardioprotection - A critical analysis. Davidson SM, Yellon DM. Mol Aspects Med. 2017 Nov 14. pii: S0098-2997(17)30141-3
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Sluijter JPG, Davidson SM*[ Joint first authors], Boulanger CM, Iren Buzás E, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P. Cardiovasc Res. 2018 Jan 1;114(1):19-34
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Hausenloy DJ, Garcia-Dorado D, Erik Bøtker H, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JP, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P. Cardiovasc Res. 2017 May 1;113(6):564-585. doi: 10.1093/cvr/cvx049
Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro Davidson SM, Riquelme J, Takov K, Vicencio Bustamante JM, Boi-Doku C, Khoo V, Doreth C, Radenkovic D, Lavandero S, Yellon D J Cell Mol Med (2017) DOI:10.1111/jcmm.13302